Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronidazole for the treatment of Dientamoeba fragilis infection in children in Denmark
2010-024657-36Phase 4Completed
- Sponsor
- Statens Serum Institut
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in dientamoebiasis and bowel dysfunction comparing Metronidazole with Placebo (2 arms). Primary endpoint: Primary: Symptom level change with metronidazole. Started Apr 2011; status: completed.
02
Drugs
metronidazole
03
Conditions
dientamoebiasisbowel dysfunction
Beyond the preview
Go deeper on 2010-024657-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024657-36.